PPXRD-11 Presentations

May 2012 – Fort Myers, Florida, USA

Presentation Title Authors
‣ Using PXRD for Amorphous Materials Simon Bates, Triclinic Labs Inc., West Lafayette, IN, USA
‣ Desolvation Of Droperidol Isostructural Solvates A. Bērziņš, University of Latvia, Rīga, Lativa
‣ Solid-Form Screening And Selection: Strategies And Challenges Of Difficult Molecules Pingyun (P.Y.) Chen, OptiformTM Technologies, Catalent, Pharma Solutions, Research Triangle Park, NC, USA
‣ Addressing The Amorphous Content Issue In Quantitative Phase Analysis: The Certification Of NIST Standard Reference Material 676A J. Cline, NIST, Gaithersburg, MD, USA
‣ Material Identification And Characterization: 10 Years Of Developments, The PDF-4/Organics Database T.G. Fawcett, ICDD, Newtown Square, PA, USA
‣ New Instrumentation For Pharmaceutical XRD B. He, AXS, Madison, WI, USA
‣ Crystal Structure Prediction: Synergy Between Theory And Experiment James A. Kaduk, Illinois Institute of Technology, Chicago, IL, USA
‣ Using Thermal Techniques for Amorphous Materials Ann Newman, Seventh Street Development Group, Lafayette, IN, USA
‣ Regulatory Considerations On Pharmaceutical Solids: Polymorphs And Co-Crystals Andre Raw, FDA, Rockville, Maryland, USA
‣ Ultrafast Lasers for the Detection and Quantification of Trace Crystallinity in Amorphous Formulations by SONICC Garth Simpson, Purdue University, West Layette, IN, USA
‣ Nucleation And The Differing Crystallization Behavior Of Enantiomers Gregory A. Stephenson, Eli Lilly and Company, Indianapolis, IN, USA
‣ Sonicc And TPE-UVF Analysis Of Apis And Common Excipients S. Toth, College of Pharmacy, Purdue University, West Lafayette, IN, USA
‣ Molecular Cocrystals And Salts: ‘Full’ Structural Characterization From Powder Diffraction Data Maryjane Tremayne, University of Birmingham, Edgbaston, Birmingham, UK
‣ Amorphous Quantitation Strategy For Crystalline Drug Substance – A GSK Perspective Peter Varlashkin, Physical Properties, GSK, Durham, NC, USA
‣ The Strategy for Quantitation of Residual Amorphous in Crystalline API Peter Varlashkin, Physical Properties, GSK, Durham, NC, USA
‣ Structural Characterization Of Solid Composite Materials As A Tool For Drug Product Formulation And Development Peter Wildfong, Duquesne University, Pittsburgh, PA, USA
‣ The Study Of Micronization Induced Disorder Of Active Pharmaceutical Ingredients By XRPD Line Broadening Analyses G. Williams, GlaxoSmithKline, Durham, NC, USA
‣ Amorphous Basics Lian Yu, University of Wisconsin, Madison, WI, USA
‣ Amorphous Organic Solids And Their Crystallization Lian Yu, University of Wisconsin, Madison, WI, USA
Scroll to Top